Senior insider sale
VP of US Regulatory & FDA Rel. at TRANSMEDICS GROUP, INC. — senior position signals high conviction
$180.1K
2.71K shares
What this filing means
PROVOST MIRIAM plans to sell 2.71K shares of TRANSMEDICS GROUP, INC. valued at approximately $180.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/31/2023ACC: 0001972362-23-000757
Officer· VP of US Regulatory & FDA Rel.
Since May 2019
2.71K
Shares to sell
$180.1K
Approx. market value
2.71K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
COMPENSATION
8/31/2023
2.71KTotal acquired2.71K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/31/2023 | STOCK OPTION EXERCISE COMPENSATION | 2.71K | — |
| Total | 2.71K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.71K
Market value
$180.1K
8/31/2023
Total
Units
2.71K
Value
$180.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/31/2023 | 2.71K | $180.1K | NASDAQ | Planned |
| Total | 2.71K | $180.1K | ||